Generalized eruptive keratoacanthomas of Grzybowski treated with isoretinoin

Presbyterian- St. Luke's Hospital, Denver, CO, USA.
Journal of drugs in dermatology: JDD (Impact Factor: 1.45). 12/2008; 7(11):1069-71.
Source: PubMed


Generalized eruptive keratoacanthomas of Grzybowski is a rare condition of unknown etiology. The disease is characterized by the abrupt onset of many small crateriform papules on the skin and mucous membranes. The authors report of a man with multiple eruptive keratoacanthomas of Grzybowski who responded favorably to oral isotretinoin therapy. After 2 years of follow-up, a complete regression of all lesions was observed, and this rapid clearance under isotretinoin therapy is intriguing with regard to the possible etiology of the condition.

4 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 71-year-old man with chronic renal failure and on peritoneal dialysis presented with recurrence of multiple keratotic nodules along a surgical scar. This was 6 months after the excision of a recurrent keratotic nodule reported as squamous cell carcinoma from the same site. The lesions were initially reported as squamous cell carcinomas, but on review of histology were consistent with keratoacanthomas. One of the keratoacanthomas showed vascular invasion. These responded well to low-dose acitretin at 10 mg three times per week and the patient stayed in remission after 18 months of follow up.
    Australasian Journal of Dermatology 09/2009; 50(3):194-7. DOI:10.1111/j.1440-0960.2009.00537.x · 1.11 Impact Factor
  • Chapter: Retinoids
    Burger's Medicinal Chemistry, Drug Discovery and Development, 09/2010; , ISBN: 9780471266945
  • [Show abstract] [Hide abstract]
    ABSTRACT: An 87-year-old woman with eruptive keratoacanthomas complicating recent imiquimod therapy is presented. Lesions developed both at and distal to the treatment site. She responded well to 8 weeks of oral acitretin with resolution of most lesions and no recurrence at 6 months post treatment. A remaining lesion was excised and found to be a well-differentiated squamous cell carcinoma. Keratoacanthoma and squamous cell carcinoma should be considered in any patient developing rapidly growing keratotic nodules in association with recent imiquimod therapy. The aetiology and treatment of eruptive keratoacanthomas is briefly discussed.
    Australasian Journal of Dermatology 02/2011; 52(1):66-9. DOI:10.1111/j.1440-0960.2010.00676.x · 1.11 Impact Factor
Show more